Acular LS vs. Nevanac in Post op Inflammation Following Cataract Surgery

Completed · Phase 4

Conditions studied: Cataract

In brief

The purpose of this study is to compare the clinical outcomes, safety and efficacy in patients randomized to receive either ketorolac or nepafanac following cataract surgery.

Key facts

Study ID

NCT00348582

Run by

Innovative Medical

Last updated by the study team

2007-06-25

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• · Male or female > 18 years of age scheduled to undergo cataract surgery
• Must be in good general health. Patients with systemic diseases will be enrolled only if there are no ocular manifestations of their disease (ie diabetics with normal retinal exams)
• Ability to provide informed consent and likely to complete all study visits

You may not qualify if…

• · Known contraindication to any study medication or any of their components
• Uncontrolled systemic disease
• Required use of ocular medications other than the study medications during the study
• Abnormal pre-operative OCTs if obtainable
• Diabetic patients
• Use of oral NSAIDS
• Patients with ocular disease (macula degeneration, glaucoma, corneal disease) which reduces the potential visual rehabilitation (patients will ocular disease that will no preclude achievement of a 20/20 visual outcome may be included)..

Where it is running

• Dr. Francis — Pittsburgh, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.